{"transactions":[{"id":839634,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":60242,"kind":"person","name":"Kyme Pierre","position":1,"cik":"0002028892","reported_name":"Kyme Pierre","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2026-03-17T23:48:27.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1030,"price":10.54,"value":10856.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":9461,"source":{"system":"sec-edgar","filing":"0001104659-26-029712","document":"tm269075-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926029712/tm269075-2_4seq1.xml","form_type":"4"}},{"id":849505,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":60242,"kind":"person","name":"Kyme Pierre","position":1,"cik":"0002028892","reported_name":"Kyme Pierre","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2026-03-12T01:18:19.000Z","date":"2026-03-09","kind":"grant","planned":false,"acquired":true,"shares":183142,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on March 9th of each of 2027, 2028, 2029, and 2030, in each case subject to continuous service through the applicable vesting date."}],"balance_after":183142,"derivative":{"exercise_price":11.61,"expiration_date":"2036-03-09","underlying":"Common Stock","underlying_shares":183142},"source":{"system":"sec-edgar","filing":"0001104659-26-026588","document":"tm268588-9_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465926026588/tm268588-9_4seq1.xml","form_type":"4"}},{"id":1165972,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":60242,"kind":"person","name":"Kyme Pierre","position":1,"cik":"0002028892","reported_name":"Kyme Pierre","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2025-04-25T20:06:15.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1027,"price":1.95,"value":2002.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":10491,"source":{"system":"sec-edgar","filing":"0001104659-25-039414","document":"tm2513168-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925039414/tm2513168-2_4seq1.xml","form_type":"4"}},{"id":1279281,"issuer":{"id":6329,"kind":"organization","name":"Armata Pharmaceuticals, Inc."},"owners":[{"id":60242,"kind":"person","name":"Kyme Pierre","position":1,"cik":"0002028892","reported_name":"Kyme Pierre","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-02-07T21:19:28.000Z","date":"2025-02-05","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the Stock Options shall vest on February 5th of each of 2026, 2027, 2028 and 2029, in each case subject to continuous service through the applicable vesting date."}],"balance_after":100000,"derivative":{"exercise_price":2.04,"expiration_date":"2035-02-05","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-25-010561","document":"tm255864-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/921114/000110465925010561/tm255864-5_4seq1.xml","form_type":"4"}}]}